Autopsy report · NCT01480531
Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection
Cause of deathSlow enrollment
“We elected to stop this study due to our inability to recruit suitable subjects.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Duke University
- Sponsor type
- University, hospital or other
- Conditions
- Aorta Aneurysm; Dissection of Aorta
- Interventions
- Clevidipine
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease
“The study was withdrawn due to not being able to recruit subjects.” - The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
“This study was halted prior to accumulating the full number of participants due to difficulty in recruiting study subjects.” - Comparing Palliative Radiotherapy With or Without Carboplatin
“The study was stopped due to insufficient recruitment.” - Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
“Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided to halt the study and not publish the results.” - P-Co-Li (Pulmonary Covid-19 Study)
“Due to recruitment we decided to withdraw the study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.